Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Kanzler

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Journal of Nutrition|June 27, 2021
Ketogenic diets consumed during radio-chemotherapy have beneficial effects on quality of life and metabolic health in patients with rectal cancerRainer J Klement, Detlef Meyer, Stefan Kanzler, et al.
Clinical Nutrition (Edinburgh, Scotland)|July 7, 2021
Impact of a ketogenic diet intervention during radiotherapy on body composition: IV. Final results of the KETOCOMP study for rectal cancer patientsRainer J Klement, Petra S Koebrunner, Detlef Meyer, et al.
Journal of Clinical Gastroenterology|January 2, 2007
Prospective randomized comparison of minilaparoscopy and percutaneous liver biopsy: diagnosis of cirrhosis and complicationsUlrike Denzer, Andrea Arnoldy, Stefan Kanzler, et al.
Gastrointestinal Endoscopy|October 7, 2003
Mini-laparoscopically guided percutaneous gastrostomy and jejunostomyUlrike Denzer, Klaus Mergener, Stefan Kanzler, et al.
Hepatology (Baltimore, Md.)|July 28, 2007
Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytesHong-Lei Weng, Loredana Ciuclan, Yan Liu, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 17, 2007
Efficacy of an escalating dose regimen of pegylated interferon alpha-2a plus ribavirin in the early phase of HCV reinfection after liver transplantationTim Zimmermann, Wulf O Böcher, Stefan Biesterfeld, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2018
Perioperative chemotherapy with or without epidermal growth factor receptor blockade in unselected patients with locally advanced oesophagogastric adenocarcinoma: Randomized phase II study with advanced biomarker program of the German Cancer Society (AIO/CAO STO-0801)Michael Stahl, Annett Maderer, Florian Lordick, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Journal of Nutrition|June 27, 2021
Ketogenic diets consumed during radio-chemotherapy have beneficial effects on quality of life and metabolic health in patients with rectal cancerRainer J Klement, Detlef Meyer, Stefan Kanzler, et al.
Clinical Nutrition (Edinburgh, Scotland)|July 7, 2021
Impact of a ketogenic diet intervention during radiotherapy on body composition: IV. Final results of the KETOCOMP study for rectal cancer patientsRainer J Klement, Petra S Koebrunner, Detlef Meyer, et al.
Journal of Clinical Gastroenterology|January 2, 2007
Prospective randomized comparison of minilaparoscopy and percutaneous liver biopsy: diagnosis of cirrhosis and complicationsUlrike Denzer, Andrea Arnoldy, Stefan Kanzler, et al.
Gastrointestinal Endoscopy|October 7, 2003
Mini-laparoscopically guided percutaneous gastrostomy and jejunostomyUlrike Denzer, Klaus Mergener, Stefan Kanzler, et al.
Hepatology (Baltimore, Md.)|July 28, 2007
Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytesHong-Lei Weng, Loredana Ciuclan, Yan Liu, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 17, 2007
Efficacy of an escalating dose regimen of pegylated interferon alpha-2a plus ribavirin in the early phase of HCV reinfection after liver transplantationTim Zimmermann, Wulf O Böcher, Stefan Biesterfeld, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2018
Perioperative chemotherapy with or without epidermal growth factor receptor blockade in unselected patients with locally advanced oesophagogastric adenocarcinoma: Randomized phase II study with advanced biomarker program of the German Cancer Society (AIO/CAO STO-0801)Michael Stahl, Annett Maderer, Florian Lordick, et al.
Pageof 1